The International Myeloma Foundation (IMF) Honors 2023 Research Achievement Awardees, Dr. Maria-Victoria Mateos and Dr. Thomas Martin
June 01, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie...
International Myeloma Foundation to Host 2023 Global Myeloma Action Network (GMAN) Summit in Frankfurt
May 25, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Founded in 2013 by the International Myeloma Foundation (IMF), the Global Myeloma Action Network (GMAN) will hold its Annual Summit in Frankfurt...
‘Crazy Guy on a Bike’ Andy Sninsky: Over 10 Years of Pedaling for Multiple Myeloma and Bringing Hope
May 18, 2023 05:45 ET
|
International Myeloma Foundation
LOS ANGELES, May 18, 2023 (GLOBE NEWSWIRE) -- Diagnosed in 2008 at age 59 with multiple myeloma, Andy Sninsky continues to be a formidable inertia in motion and a perpetual source of inspiration for...
The Annual Czerkies Memorial Golf Outing: 15 Years of Helping the International Myeloma Foundation (IMF) Find a Cure for Multiple Myeloma
May 16, 2023 05:45 ET
|
International Myeloma Foundation
A Media Snippet accompanying this announcement is available by clicking on the image or link below: LOS ANGELES, May 16, 2023 (GLOBE NEWSWIRE) -- Now on its 15th year, the Annual Czerkies...
The International Myeloma Foundation (IMF) Launches Medical Student Scholars for Health Equity in Myeloma Mentoring Program
April 20, 2023 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a...
Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology Conference
April 10, 2023 16:05 ET
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced...
One Community, One Question: What Is Your #MYelomaSTORY?
April 06, 2023 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month (MAM), the International Myeloma Foundation (IMF) was truly grateful for everyone’s...
The International Myeloma Foundation Announces the Annual Miles for Myeloma 5K Run/Walk: 15 Years of Making a Difference in the Myeloma Community
April 03, 2023 08:45 ET
|
International Myeloma Foundation
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- The Annual Miles for Myeloma Hybrid 5K Run/Walk will once again “Redefine Being Together” on Saturday, April 29, virtually and in-person at FDR Park...
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 27, 2023 16:05 ET
|
Harpoon Therapeutics
HPN217 (BCMA) and HPN328 (DLL3) enrollment on track, with data updates and selection of recommended Phase 2 doses for both active clinical programs planned in 2023 Completion of $25 million...
Harpoon Therapeutics Announces Closing of $25 Million Private Placement
March 27, 2023 16:02 ET
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP) (the “Company”), a clinical-stage immuno-oncology company developing novel T cell engagers,...